Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

20 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Gantanol Articles

US retail chain drops discount drug plan in favor of free antibiotics

20 August 2007

Pafuramidine gets OD status for PCP

27 November 2006

Immtech's PCP drug enters Ph III US trial

3 April 2006

Able Labs gets first NDA cleared in USA

27 June 2001

India's NPPA reduces five bulk drug prices

20 July 2000

Bentley Pharma Deal With Juventus Spain

19 February 1996

Burroughs Wellcome

22 May 1995

Cortech Lodges IND For Sulfasim

20 March 1995

Cortech Reflects On Year Of Mixed Fortune

27 February 1995

Quarterly Results From Smaller US Drug Firms

22 August 1994

Cortech Sepsis Drug Joins Failure List

1 August 1994

ROCHE'S BACTRIM APPROVED FOR PCP

17 January 1994

JAPAN NEWS IN BRIEF

10 January 1994

US BIOSCIENCE'S AIDS-RELATED DRUG APPROVED

10 January 1994

NEW NHI LIST ADDITIONS IN JAPAN

20 December 1993

NIPPON ROCHE TO FILE NDA IN JAPAN

11 October 1993

NEW PRODUCTS APPROVED BY JAPAN'S CPAC

27 September 1993

NEUTREXIN TREATMENT IND

21 June 1993

ATOVAQUONE VERSUS CO-TRIMOXAZOLE

31 May 1993

US BIOSCIENCE FILES NDA

1 March 1993

COMPARATIVE TRIALS OF PCP DRUGS

18 January 1993

Showing 1-21 of 21 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS